“Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s428. doi:10.25251/skin.8.supp.428.